- Home
- WGS vs DXYZ Comparison
WGS vs DXYZ Comparison
Compare WGS & DXYZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WGS | DXYZ |
|---|---|---|
| Founded | 2017 | N/A |
| Country | United States | |
| Employees | 1300 | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | |
| Sector | Technology | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.3B |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | WGS | DXYZ |
|---|---|---|
| Price | $64.75 | $23.12 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $120.71 | N/A |
| AVG Volume (30 Days) | 642.9K | ★ 986.2K |
| Earning Date | 05-04-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $29.98 | N/A |
| Revenue Next Year | $25.92 | N/A |
| P/E Ratio | $1,251.58 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $32.21 | $19.71 |
| 52 Week High | $170.87 | $72.87 |
Technical Indicators
Market Signals| Indicator | WGS | DXYZ |
|---|---|---|
| Relative Strength Index (RSI) | 55.10 | 39.79 |
| Support Level | $56.36 | $19.71 |
| Resistance Level | $73.21 | $29.56 |
| Average True Range (ATR) | 4.56 | 1.50 |
| MACD | 0.09 | 0.18 |
| Stochastic Oscillator | 64.86 | 25.64 |
Price Performance
Historical ComparisonAbout WGS GeneDx Holdings Corp.
GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.
About DXYZ Destiny Tech100 Inc.
Destiny Tech100 Inc is a non-diversified, closed-end management investment company. It is designed to be an investment portfolio of the Top 100 High-Growth Tech Companies.